COLL vs TECH
Collegium Pharmaceutical Inc (COLL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the COLL and TECH stock pages for the full models.
Not investment advice.